Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome

计划入组 420 人 · 首次发布于 2016 年 2 月 17 日

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

计划入组 60 人 · 首次发布于 2025 年 10 月 10 日

Invasive Group A Streptococcal Infection

计划入组 100 人 · 首次发布于 2023 年 3 月 29 日

Infection(alphamol)

HER-096

Trivalent Invasive Salmonella Disease Vaccine(University of Maryland)

FIRST MEDICAL INFECTION CONTROL ASSOCIATES, INC.

United States

B. Braun Ltd. Centre of Excellence Infection Control

Orsi Academy

Belgium

Elion Therapeutics Initiates Phase 2 Trial of Turletricin for Invasive Mould Infections

Persistent SARS-CoV-2 Infection Linked to Long COVID Symptoms in New Study

Basilea Launches Phase 3 Trial for Novel Antifungal Fosmanogepix in Invasive Mold Infections